ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Energy Transfer shares hit 52-week high above $21 as earnings top estimates

Energy Transfer’s stock surged to a 52-week peak of $21.12 as Q2 adjusted EBITDA rose 30.8% and full-year guidance was lifted. Dividend yield holds at 6.5%.

PA
Priya Anand · Equities & Earnings Desk · 19 Aug 2026 · 07:53 · 1 min read
Share
Energy Transfer shares hit 52-week high above $21 as earnings top estimates

Energy Transfer LP’s stock climbed to a 52-week high of $21.12 on Tuesday, extending a year-to-date gain of 34% as the pipeline operator reported adjusted earnings that exceeded analyst forecasts.

The company’s adjusted earnings per share for the second quarter of 2026 reached $0.59, surpassing the $0.37 estimate compiled by TD Cowen. Adjusted EBITDA rose 30.8% year-over-year to approximately $5.1 billion, driven by stronger performance in the Marketing segment. Energy Transfer also raised its full-year EBITDA guidance, citing continued operational momentum.

The stock was last quoted at $21.15, up 1.40%, after closing at $21.05 on Monday. Over the past 12 months, shares have gained 20.69%, contributing to a dividend yield of 6.5%. The company has increased its dividend annually for four consecutive years and maintained payouts for 21 straight years.

TD Cowen lifted its price target on Energy Transfer to $25 from $24, reflecting the improved earnings outlook. The company’s Green Chile Project pipeline in New Mexico, intended to supply an Oracle Corp. data center, remains on track for a revised start date of February 1, 2027, following a delay from the original August 2026 target.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT